On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment grants that will bring two CPRIT Scholars from out-of-state institutions to Texas to expand their cancer research and add to the stateﾒs growing cancer research prowess.

The Houston Methodist Research Institute is recruiting Dr. Keith Chan, a widely respected genitourinary cancer translational scientist currently at Cedars-Sinai Medical Center in Los Angeles, California, to Texas with a $6 million CPRIT Established Investigator award.

The University of Texas MD Anderson Cancer Center is attracting another premier candidate, Dr. Rugang Zhang, to chair the Department of Experimental Therapeutics at MD Anderson. Dr. Zhang is an internationally recognized ovarian cancer researcher at the Wistar Cancer Institute in Philadelphia.